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Esophageal cancers usually exhibit lymph-node metastases.  Although a solitary lymph-node metastasis 
is occasionally found,  the involvement of an intrathoracic paraaortic node is rare.  We present here an 
intrathoracic mid-esophageal cancer case in which an accompanying solitary retroaortic mass was 
found within the posterior mediastinum by integrated positron emission tomography/computed tomog-
raphy.  For diagnosis,  thoracoscopic resection of the mass was performed from a left thoracic 
approach,  and histology revealed it to be a squamous cell carcinoma metastasized from the esopha-
geal cancer.  Upon radical esophagectomy after neoadjuvant therapy as a T3N1M0 Stage IIIa (AJCC/
UICC) cancer,  the esophageal cancer was found to have invaded unexpectedly deeply in the vicinity of 
the descending aorta.  Another lymph node within the paraaortic region was also involved (T4N1M0 
Stage IIIc).  The present case and other cases we review here inform our understanding of metastasis 
to intrathoracic paraaortic nodes as follows: 1) its existence may indicate extensive lymph-node metas-
tasis or direct tumor invasion nearby,  and 2) it may be accompanied by other lymph-node involve-
ments in this region,  even if it appears solitary upon preoperative investigation.  Thus,  for radical 
esophagectomy,  suﬃcient lymph-node dissection is required,  even at locations not reached by the usual 
right thoracic approach.  Deﬁnitive chemoradiotherapy may be a better choice for preoperatively 
recognized T3 esophageal cancer when the cancer is accompanied by paraaortic lymph node metasta-
sis.
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sophageal cancer is a highly aggressive tumor 
with a poor long-term outcome,  and surgery is 
still considered the best choice for a cure [1].  It is 
commonly accompanied by lymph-node metastasis,  and 
this strongly inﬂuences the patientsʼ prognosis after 
esophagectomy [1,  2].  However,  metastasis to an 
intrathoracic paraaortic lymph-node (ITPAN) is rare;  
indeed,  only 3 operated cases have been reported so 
far [3,  4].  Here,  we present an esophageal cancer 
case that on preoperative imaging appeared to be 
accompanied by only a solitary ITPAN metastasis,  
and we discuss its implications for tumor extension 
and therapy.
Case Report
　 A 66-year-old Japanese man was referred to the 
National Defense Medical College Hospital 
(Tokorozawa,  Japan) from a local hospital with a 
diagnosis of esophageal cancer.  He had a history of 
E
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heavy alcohol intake and smoking.  He had suﬀered 
from epigastralgia for 2 months.  Upon admission,  his 
laboratory data were unremarkable,  and the serum 
values of carcinoembryonic antigen,  cytokeratin-19 
fragment,  and squamous cell carcinoma (SCC) antigen 
were each within the normal range.  Both esophagog-
raphy and upper endoscopy revealed a 5-cm Borrmann 
type-2 tumor within the mid-thoracic portion of the 
intrathoracic esophagus (Fig.  1A),  and histology of 
biopsy samples taken from that tumor revealed SCC,  
G2.  However,  computed tomography (CT) of the chest 
displayed a mass behind the intrathoracic descending 
aorta,  in addition to the predicted mid-thoracic 
esophageal cancer (Fig.  1B),  while 18ﬂuoro-deoxyglu-
cose (FDG)-positron emission tomography (PET)/CT 
revealed abnormally high FDG uptakes at those sites 
(Fig.  1C).  No abnormal FDG uptake values were 
observed at other sites.
　 We considered whether the retroaortic mass might 
be an ITPAN metastasis from the esophageal cancer,  
a benign granulomatous inﬂammation,  or another 
entity,  since a solitary ITPAN metastasis from an 
esophageal cancer is rare and an elevated FDG uptake 
does not necessarily indicate a malignancy [5].  A 
further problem was that the location of the mass 
meant that it could not easily be approached during the 
usual one-stage resection for a mass and a mid-esoph-
ageal cancer using a right thoracic approach.  Thus,  a 
2-stage operation was planned,  and for resection of the 
mass we selected thoracoscopic resection using a left 
thoracic approach as the ﬁrst procedure,  followed by 
esophagectomy using a right thoracic approach,  since 
it would be less invasive.  During the ﬁrst procedure,  
the mass was found on the dorsal surface of the 
intrathoracic descending aorta at the 8th vertebral 
level (Fig.  2A).  It was easy to detach from the aorta,  
and cancer invasion was indistinct there.  Histology 
revealed the mass to be a destructured lymph node due 
to metastatic deposits of SCC (Fig.  2B),  a ﬁnding 
consistent with a T3N1M0 Stage IIIa (AJCC/UICC 
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Fig. 1　 Imaging studies of the esophageal cancer and the paraaortic mass.  A,  Esophagography revealed an esophageal cancer forming 
an irregular crater within the intrathoracic mid-esophagus (arrows); B,  Chest computed tomography displayed a mass (arrowheads) poste-
rior to the descending aorta; C,  18Fluoro-deoxyglucose-positron emission tomography revealed an abnormally elevated uptake of ﬂuoro-
deoxyglucose at the site of the paraaortic mass (arrowhead) as well as at that of the esophageal cancer (arrow).
[6]) esophageal cancer.
　 The patient received neoadjuvant therapy (2 cycles 
of cisplatin 80mg/m2 on day 1 and 5-ﬂuorouracil 
800mg/m2 on days 1-5,  with a 4-week interval).  
However,  imaging showed this to have caused only a 
minimal improvement in the esophageal cancer,  which 
could not deny its periaortic invasion (Fig.  3).  PET/
CT was not performed at that time.  A radical 
esophagectomy was performed using a right thoracic 
approach 8 weeks after termination of the neoadjuvant 
therapy.  During the operation,  the esophageal cancer 
was found to have extended into the periaortic tissue,  
where the tumor remained after the esophagectomy.  
In the resected specimen,  an ulcerated tumor,  sized 
52×29mm,  was located within the mid-thoracic 
esophagus.  Histology revealed a trabecular and nested 
proliferation of SCC cells.  The tumor cells invaded 
the adventitia of the esophageal wall and were exposed 
at the detached surgical margin near the aorta.  
Lymphovascular invasion by tumor cells was observed 
at the primary site,  and SCC deposits were observed 
within 2 upper paraesophageal lymph nodes and an 
ITPAN,  which were all excised during the operation.  
The ﬁnal diagnosis was G2 SCC,  T4N1M0.  The 
post-operative period was uneventful,  and the patient 
has been followed up with chemotherapy.  There has 
been no sign of either tumor regrowth or metastases 
in the 2 years since the operation.
Discussion
　 Esophageal cancers usually exhibit lymph-node 
metastasis.  In published autopsy series [7-9],  about 
60-70ｵ of patients with esophageal cancer have dis-
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Fig. 2　 Intraoperative and pathologic ﬁndings for the paraaortic lymph-node metastasis.  A,  Upon thoracoscopy,  a swollen lymph node 
(arrowheads) was seen posterior to the descending aorta; B,  The lymph node was histologically replaced by proliferating squamous cancer 
cells,  with extensive necrosis (hematoxylin-eosin stain; scale bar indicates 1 mm).
Fig. 3　 Chest computed tomography after the neoadjuvant ther-
apy.  The boundary between the esophageal cancer and the 
descending aorta (arrows) was indistinct.
played metastatic deposits within the lymph nodes.  
Although the location of the esophageal cancer within 
the esophagus (viz.  upper,  mid,  or lower intratho-
racic,  or abdominal portion) tends to inﬂuence the site 
of lymph-node metastasis,  extensive propagation can 
occur in esophageal cancer [10,  11].  Therefore,  
radical esophagectomy with 3-ﬁeld (cervical,  medi-
astinal,  and abdominal) lymph-node dissection has been 
recommended for intrathoracic esophageal cancers 
[12].  However,  it has been found that esophageal 
submucosal lymphatics drain longitudinally to perigas-
tric and/or cervical (including recurrent nerve) lymph 
nodes,  and that when tumors penetrate into the proper 
muscle layer or deeper,  then paraesophageal lymph 
nodes will be involved segmentally [13,  14].  Thus,  
most instances of solitary lymph-node metastasis occur 
within the perigastric or cervical region [13].  In the 
present case,  a single ITPAN (within the posterior 
mediastinum) was revealed to be swollen and positive 
by preoperative PET/CT.  There have been only 3 
published cases in which esophageal cancer was found 
to involve an ITPAN within the pre- or peri-operative 
period [3,  4].  From the rarity of such involvement,  
ITPANs are supposed not to receive drainage directly 
from the lymphatics embedded in the esophageal wall;  
that is to say,  the Japanese guidelines for the clinical 
and pathologic aspects of esophageal carcinoma treat 
ITPANs as compartment 3 for intrathoracic mid-
esophageal carcinoma [15].  ITPANs are nodes of the 
para-aorto-esophageal nodes that are located in the 
vicinity of the aorta and lie along the bilateral grooves 
formed between the esophagus and aorta [16]: The 
aortic wall is surrounded by a lymphatic meshwork 
that does not penetrate the aortic walls [17] and 
drains to the ITPANs; from there,  the upper lym-
phatics seem to drain into the parabronchial lymph 
nodes and the lower ones to the thoracic duct or the 
cistern chyli [16].
　 In 2 of the 3 published surgical cases with ITPAN 
involvement (i.e.,  excluding the present case),  metas-
tasis to ITPAN was suspected preoperatively.  The 
primary tumors were all located within the intratho-
racic mid-esophagus,  were SCC,  showed lymphovas-
cular invasion,  and were considered to have inﬁltrated 
at the level of the proper muscle layer or adventitia of 
the esophageal wall (in one case,  although the cancer 
invasion was reported to be limited to the level of the 
deep submucosal layer of the esophageal wall,  it was 
accompanied by local cancer proliferation within the 
adventitial tissue [3]).  Apart from ITPAN,  these 3 
cases exhibited relatively extensive or widely propa-
gated lymph-node metastasis: one case involved cervi-
cal,  recurrent nerve,  and perigastric lymph nodes;  
the second case cervical; and the third case recurrent 
nerve,  paratracheal,  paraesophageal,  and perigastric.  
An extensive tumor burden in the lymphatics (such as 
in certain autopsy cases and the above 3 cases) could 
be responsible for the ﬁndings of metastatic deposits 
within the ITPANs.  However,  the present case did 
not show such extensive lymph-node involvement,  and 
the metastasis may have been due to the deep cancer 
invasion into the aortic wall.
　 From the above considerations,  an extensive or 
widely propagated lymph-node involvement of the 
cancer or direct tumor invasion in the vicinity of the 
aorta was considered as the possible cause of the 
ITPAN metastases.  Interestingly,  in 2 of the 3 pub-
lished cases,  recurrence occurred within ITPANs.  
The present case also had an involvement of another 
ITPAN within the specimens resected during the 
operation.  Excluding one case whose postoperative 
local status in the posterior mediastinum was not 
available [4],  the other 2 published cases and the 
present case each had 2 or more involved lymph nodes 
within this paraaortic region.  From this,  we infer 
that ITPAN involvement in cases of esophageal cancer 
is likely not solitary,  even if the involvement of other 
nodes is indistinct on imaging.
　 Whether or not this inference is always justiﬁed,  
we suggest that if radical cure is expected,  suﬃcient 
lymph-node dissection should be carried out for an 
esophageal cancer that is accompanied by any ITPAN 
swelling.  In the present case,  we unfortunately selected 
thoracoscopic resection for the ﬁrst stage of the two-
stage operation,  and therefore suﬃcient lymph-node 
dissection in the paraaortic region was not performed.  
Such dissection in the region of the posterior medi-
astinum requires operation from the left thoracic 
approach.  However,  this approach has limits for dis-
section of the neck or of the tissue in the vicinity of 
the right recurrent nerve or the right lung hilar lymph 
nodes.  In one of the 3 previously reported cases with 
ITPAN involvement,  an unusual operative approach 
was adopted [4]: namely,  a left thoracic incision,  
accompanied by resection of the manubrium of the 
sternum and dislocation (turn) of the aortic arch,  to 
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provide suﬃciently wide operative ﬁelds for dissection 
of these regions.  If the dissection were found to be 
unsatisfactory,  a particularly careful follow-up would 
of course be required.  Upon reﬂection,  in the present 
case it might have been better to have considered 
deﬁnitive chemoradiotherapy instead of surgery-based 
therapy.  In Japan,  T3-Stage III patients are generally 
recommended to receive neoadjuvant chemotherapy 
plus surgery [18].  Deﬁnitive chemoradiotherapy 
remains an alternative treatment because of its late 
toxicity and because there is the possibility of salvage 
surgery [18].  Actually,  with the inferences drawn 
from the previous ITPAN-positive cases,  in which 
there was the possibility of either periaortic invasion 
or involvement of another ITPAN that would be diﬃ-
cult to dissect,  deﬁnitive chemoradiotherapy might be 
the ﬁrst-choice therapeutic modality in such cases.
　 In conclusion,  we present here an esophageal can-
cer patient with ITPAN metastasis.  Even if the 
ITPAN swelling initially appears to be solitary,  such 
cases may have extensive lymph-node involvement or 
direct cancer invasion in the vicinity of the aorta.  
Suﬃcient lymph-node dissection,  including this region,  
should be considered as an adjunct to the radical 
operation,  and a therapeutic modality for T4 or stage 
IV esophageal cancer may be a suitable selection for 
such cases.
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